RESPIRATORY
Delivering Care with Confidence
Our respiratory solutions are developed to address chronic and acute conditions with precision, improving patient outcomes and quality of life across every breath.
Product Chart
Our production process is an extension of our promise, where every step is designed with intention: to uphold the highest standards, accelerate access to essential medicines, and support the Kingdom’s 2030 vision.
ONSTERA®
10 mg Tablets
(Montelukast Sodium)
PRODUCT SUMMARY
INDICATION
A leukotriene receptor antagonist indicated in the treatment of asthma as add-on therapy in those patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom “as-needed” short acting beta-agonists provide inadequate clinical control of asthma.
ADMINISTRATION
Onstera can also provide symptomatic relief of seasonal allergic rhinitis.
DOSAGE
Once-daily oral dose.
Available in packs of 30 film-coated tablets.
COMPLIANCE
Compliant with GINA 2024 guidelines for mild asthma.
Marketed by Doctors Pharma, KSA.